We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+8.37%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$106M
AUM Growth
+$36.4M
Cap. Flow
+$27.7M
Cap. Flow %
26.07%
Top 10 Hldgs %
7.92%
Holding
512
New
277
Increased
40
Reduced
25
Closed
170

Top Buys

Rank Stock Value
1
GIS icon
General Mills
GIS
+$1.06M
2
LULU icon
lululemon athletica
LULU
+$859K
3
ACN icon
Accenture
ACN
+$832K
4
HRL icon
Hormel Foods
HRL
+$758K
5
XLNX
Xilinx Inc
XLNX
+$756K

Sector Composition

Rank Sector Weight
1 Technology 24.22%
2 Consumer Discretionary 19.81%
3 Industrials 12.39%
4 Healthcare 10.6%
5 Consumer Staples 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAB icon
226
Wabtec
WAB
$50.8B
$244K 0.23%
+3,076
New +$213K
UN
227
DELISTED
Unilever NV New York Registry Shares
UN
$242K 0.23%
+5,412
New +$233K
RWT
228
Redwood Trust
RWT
$619M
$239K 0.23%
+18,300
New +$214K
INGN icon
229
Inogen
INGN
$171M
$238K 0.22%
+5,300
New +$189K
SHOP icon
230
Shopify
SHOP
$165B
$238K 0.22%
+84,490
New +$200K
AMAG
231
DELISTED
AMAG Pharmaceuticals
AMAG
$236K 0.22%
+10,100
New +$240K
PODD icon
232
Insulet
PODD
$11.4B
$235K 0.22%
7,100
-900
-11% -$28.3K
BKU icon
233
Bankunited
BKU
$3.36B
$234K 0.22%
+6,800
New +$228K
OTEX icon
234
Open Text
OTEX
$5.73B
$233K 0.22%
+9,000
New +$217K
TBI
235
Trueblue
TBI
$237M
$233K 0.22%
8,900
+900
+11% +$20.8K
GIMO
236
DELISTED
Gigamon Inc.
GIMO
$233K 0.22%
+7,496
New +$196K
SEM
237
DELISTED
Select Medical
SEM
$232K 0.22%
+36,509
New +$196K
GSK icon
238
GSK
GSK
$104B
$231K 0.22%
4,552
-1,345
-23% -$67K
BABA icon
239
Alibaba
BABA
$276B
$229K 0.22%
2,894
-506
-15% -$35.6K
STGW icon
240
Stagwell
STGW
$1.92B
$229K 0.22%
+9,700
New +$197K
GTLS
241
DELISTED
Chart Industries
GTLS
$226K 0.21%
+10,425
New +$186K
UL icon
242
Unilever
UL
$132B
$225K 0.21%
+4,424
New +$215K
BRC icon
243
Brady Corp
BRC
$4.54B
$224K 0.21%
+8,340
New +$201K
ICUI icon
244
ICU Medical
ICUI
$4.04B
$224K 0.21%
2,150
+7
+0.3% +$669
NVDA icon
245
NVIDIA
NVDA
$4.76T
$224K 0.21%
251,280
-360,000
-59% -$275K
SHPG
246
DELISTED
Shire pic
SHPG
$224K 0.21%
+1,303
New +$218K
FCN icon
247
FTI Consulting
FCN
$4.88B
$220K 0.21%
+6,189
New +$207K
GRPN icon
248
Groupon
GRPN
$1.05B
$220K 0.21%
+2,755
New +$190K
UFPI icon
249
UFP Industries
UFPI
$4.98B
$220K 0.21%
+7,692
New +$183K
LCII icon
250
LCI Industries
LCII
$2.52B
$219K 0.21%
+3,400
New +$200K

Similar funds

Bayesian Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Bayesian Capital Management held 512 positions worth $106M, up 52% from $69.8M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Bayesian Capital Management deployed $27.7M of net new capital in Q1 2016, opening 277 new positions and adding to 40 existing holdings. Its largest new stake was General Mills: 18,156 shares worth $1.15M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $278K trimmed.

  • Bayesian Capital Management's largest Q1 2016 buy was General Mills: 18,156 shares worth $1.15M.
  • Bayesian Capital Management added most to Accendra Health in Q1 2016, an estimated $279K increase.
  • Bayesian Capital Management's biggest Q1 2016 reduction was Alphabet (Google) Class A, cutting an estimated $278K.
  • Bayesian Capital Management fully exited Apple in Q1 2016, selling an estimated $1.42M.
  • Bayesian Capital Management's ten largest holdings make up 7.9% of its $106M portfolio in Q1 2016.
  • Bayesian Capital Management opened 277 new positions and closed 170 in Q1 2016.
  • Bayesian Capital Management's portfolio value rose 52% quarter-over-quarter to $106M.

Based on Bayesian Capital Management's 13F filing for Q1 2016, filed 16 May 2016.